港股異動丨東方甄選大跌約10% 較3個月前高位已累跌逾44%
東方甄選(1797.HK)大跌9.95%至16.66港元,或將創下2024年10月中旬以來的最大收盤跌幅。該股曾於2024年10月3日盤中觸及階段高位30港元,迄今僅僅3個月時間,股價已累跌逾44%。高盛曾發研報指,維持東方甄選“沽售”評級,將其目標價8.3港元下調至8.2港元。該行表示,從新東方的業績可推論東方甄選在截至8月的季度收入為1.57億元,意味非通用會計準則經營虧損為1,050萬元,相當於非通用會計準則經營利潤負7%。因此,該行下調公司2025財年的商品成交金額及收入預測8%及10%,並降其經調整經營利潤預測2.3個百分比。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.